In this project, we aimed to determine the effects of the ERα Y537S mutation on ERα/PR crosstalk and resulting transcriptional activity, and to elucidate how this unique interaction contributes to ET resistance in ERα-positive breast cancer. Here, ESR1 is linked to breast cancer.